Glenmark Pharmaceuticals informs about integrated annual report

27 Aug 2022 Evaluate

Pursuant to Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Glenmark Pharmaceuticals has informed that it attached the Integrated Annual Report for the Financial Year 2021-22. The Annual Report is being sent through electronic mode to all those members whose e-mail ids have been registered with the Company/ Depository Participant/ Registrar and Transfer Agent and the same is also being made available on the website of the Company, at: www.glenmarkpharma.com.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1980.20 9.45 (0.48%)
27-Jan-2026 12:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1632.80
Dr. Reddys Lab 1241.40
Cipla 1313.80
Zydus Lifesciences 889.80
Lupin 2148.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×